Icon

ONPATTRO (nda210922)- (EQ 10MG BASE/5ML (EQ 2MG BASE/ML))

PATISIRAN SODIUM ALNYLAM PHARMS INC
EQ 10MG BASE/5ML (EQ 2MG BASE/ML)
No No
2035-Aug-27 2023-Aug-10
None None
None No
ONPATTRO contains a transthyretin-directed small interfering RNA and is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 10MG BASE/5ML (EQ 2MG BASE/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.